20.703 articles found

Targeting muscarinic receptor subtypes as a therapeutic approach in dystonia and Parkinson's disease

Klisko DM.

· 2017-01-01

The effect of L-dopa and neuroprotective agents on cell replacement therapy for Parkinson's disease

Elabi O.

· 2017-01-01

Investigating novel therapeutic approaches and targets to prevent synapse degeneration

Amorim IDS.

· 2017-01-01

Establishing C. elegans as a high-throughput system for the identification of novel therapeutic strategies for Parkinson's disease

Perni M.

· 2017-01-01

DOI: 10.17863/cam.17076

A gene therapy approach to Childhood Parkinsonism

Ng J.

· 2017-01-01

Potential for Stem Cells Therapy in Alzheimer's Disease: Do Neurotrophic Factors Play Critical Role?

Bali P, Lahiri DK, Banik A, Nehru B, Anand A.

Curr Alzheimer Res · 2017-01-01

DOI: 10.2174/1567205013666160314145347PMID: 26971940

ROCK in CNS: Different Roles of Isoforms and Therapeutic Target for Neurodegenerative Disorders.

Chong CM, Ai N, Lee SM.

Curr Drug Targets · 2017-01-01

DOI: 10.2174/1389450117666160401123825PMID: 27033194

MicroRNAs in Neurocognitive Dysfunctions: New Molecular Targets for Pharmacological Treatments?

Nadim WD, Simion V, Benedetti H, Pichon C, Baril P, Morisset-Lopez S.

Curr Neuropharmacol · 2017-01-01

DOI: 10.2174/1570159x14666160709001441PMID: 27396304

Unilateral Subthalamic Nucleus Stimulation in the Treatment of Asymmetric Parkinson"s Disease with Early Motor Complications.

Sobstyl M, Zabek M, Zaczynski A, Gorecki W, Mossakowski Z, Brzuszkiewicz-Kuzmicka G.

Turk Neurosurg · 2017-01-01

DOI: 10.5137/1019-5149.jtn.14894-15.0PMID: 27593744

Treatment Possibilities for Psychosis in Parkinson's Disease with An Emphasis on the Newly Approved Drug: Pimavanserin.

Majlath Z, Obal I, Vecsei L.

CNS Neurol Disord Drug Targets · 2017-01-01

DOI: 10.2174/1871527315666161006104347PMID: 27719624

Primary Choroid Plexus Tissue for Use in Cellular Therapy.

Sandrof MA, Emerich DF, Thanos CG.

Methods Mol Biol · 2017-01-01

DOI: 10.1007/978-1-4939-6364-5_19PMID: 27738941

Epigenetic Biomarkers for Parkinson's Disease: From Diagnostics to Therapeutics.

Jakubowski JL, Labrie V.

J Parkinsons Dis · 2017-01-01

DOI: 10.3233/jpd-160914PMID: 27792016